⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11470279 | 0.98 | — | — | |
| Ammonia Solution, Strong SCHEMBL7288994 | 0.98 | — | — | |
| SCHEMBL5530480 | 0.95 | — | — | |
| SCHEMBL2997593 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL29243589 | 0.93 | — | — | |
| SCHEMBL6695674 | 0.91 | OPRD1 (0.47) | — | |
| SCHEMBL7244706 | 0.91 | SPHK2 (0.49) | — | |
| SCHEMBL11480291 | 0.91 | ALDH1A1 (0.54) | — | |
| SCHEMBL28627062 | 0.88 | — | — | |
| SCHEMBL6853109 | 0.87 | CCR3 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1657 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11040053-B2 | Compositions and methods for activating “stimulator of interferon gene”13 dependent signalling | CHINOOK THERAPEUTICS, INC. (US) | 2021-06-22 | — | — | US | claimed |
| US-20200179431-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING \"STIMULATOR OF INTERFERON GENE\" - DEPENDENT SIGNALLING | Aduro Biotech, Inc. (US) | 2020-06-11 | — | — | US | claimed |
| US-10449211-B2 | Compositions and methods for activating “stimulator of interferon gene”—dependent signalling | Aduro Biotech, Inc. (US) | 2019-10-22 | — | — | US | claimed |
| US-20180064745-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING \"STIMULATOR OF INTERFERON GENE\" - DEPENDENT SIGNALLING | Aduro Biotech, Inc. (US) | 2018-03-08 | — | — | US | claimed |
| EP-3268035-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING \"STIMULATOR OF INTERFERON GENE\" -DEPENDENT SIGNALLING | Aduro BioTech, Inc. (US) | 2018-01-17 | — | — | EP | claimed |
| WO-2016145102-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING \"STIMULATOR OF INTERFERON GENE\" -DEPENDENT SIGNALLING | Aduro Biotech, Inc. (US) | 2016-09-15 | — | — | WO | claimed |
| US-20130150323-A1 | USE OF ORAL HEPARIN PREPARATIONS TO TREAT URINARY TRACT DISEASES AND CONDITIONS | Urigen Pharmaceuticals, Inc (US) | 2013-06-13 | — | — | US | claimed |
| EP-2531202-A2 | USE OF ORAL HEPARIN PREPARATIONS TO TREAT URINARY TRACT DISEASES AND CONDITIONS | Parsons, Lowell C. (US) | 2012-12-12 | — | — | EP | claimed |
| WO-2011097148-A2 | USE OF ORAL HEPARIN PREPARATIONS TO TREAT URINARY TRACT DISEASES AND CONDITIONS | PARSONS LOWELL C (US) | 2011-08-11 | — | — | WO | claimed |
| EP-4007758-B1 | BIS-[N-((5-CARBAMOYL)-1H-BENZO[D]IMIDAZOL-2-YL)-PYRAZOL-5-CARBOXAMIDE] DERIVATIVES AND RELATED COMPOUNDS AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS FOR THE TREATMENT OF CANCER | MERSANA THERAPEUTICS INC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-20260109665-A1 | C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260083838-A1 | Adjuvant Composition Comprising STING Agonists | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2026-03-26 | — | — | US | disclosed |
| US-20260083769-A1 | 2-Aminopropane-1,3-Diol-Capped Cationic Peptoids for Nucleic Acid Delivery | MEDICI THERAPEUTICS, INC. | 2026-03-26 | — | — | US | disclosed |
| US-20260055132-A1 | TLR7 AGONISTS | PRIMMUNE THERAPEUTICS INC (US) | 2026-02-26 | — | — | US | disclosed |
| EP-0101199-A1 | Beta-lactam compounds | BEECHAM GROUP PLC (GB) | 1984-02-22 | — | — | EP | disclosed |
| EP-0093564-A1 | Beta-lactam antibiotics | BEECHAM GROUP PLC (GB) | 1983-11-09 | — | — | EP | disclosed |
| EP-0092986-A1 | Penicillins, a process for their preparation and compositions containing them | BEECHAM GROUP PLC (GB) | 1983-11-02 | — | — | EP | disclosed |
| EP-0091755-A1 | Penicillin derivatives, a process for their preparation and compositions containing them | BEECHAM GROUP PLC (GB) | 1983-10-19 | — | — | EP | disclosed |
| EP-0091302-A1 | Beta-lactam derivatives | BEECHAM GROUP PLC (GB) | 1983-10-12 | — | — | EP | disclosed |
| EP-0090656-A1 | Penicillins, a process for the preparation and compositions containing them | BEECHAM GROUP PLC (GB) | 1983-10-05 | — | — | EP | disclosed |